Although arginine-vasopressin (AVP) is reported to produce greater ACTH biosynthetic and secretory responses than does corticotropin-releasing hormone (CRH) 
Introduction
Synthesis and secretion of adrenocorticotropin (ACTH) by the corticotrophs of the anterior pituitary are influenced by a number of hypothalamic factors, among which the most potent are corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP). In most mammalian species studied, CRH is a more potent secretagogue than AVP (Axelrod & Reisine 1984 , Antoni 1986 , Labrie et al. 1987 . CRH, but not AVP, has also been reported to stimulate the expression of the mRNA for the ACTH precursor, pro-opiomelanocortin (POMC), in human and rat corticotrophs, and in the murine celi line AtT20 (Affolter & Reisine 1985 , Gagner & Drouin 1985 , Eberwine et al. 1987 , Levin et al. 1989 ).
In sheep, the relative roles of CRH and AVP appear to be reversed. AVP produces a greater maximum response in terms of ACTH secretion than does CRH in ovine cells in vitro, and AVP also produces a biosynthetic response in sheep cells (Familari et al. 1989 , Liu et al. 1990 , Kemppainen et al. 1993 ). Analogous to the role ofCRH in rodent corticotrophs, it was assumed that AVP in sheep would increase levels of POMC mRNA, but Levin et al. (1993) Time-course of effect of AVP Cells representing the vehicle-and Cx-pretreatment groups were incubated for 2-5 h, 5 h or 24 h in DMEM:F12:polypep (2-0 ml) that contained either vehicle or AVP (100 µ). At the con¬ clusion of the respective incubations, the media were retrieved and stored, and the cells frozen as described above.
Concentration dependence of effect of AVP Cells representing the vehicle-and Cx-pretreatment groups were incubated for 5 h in DMEM:F12:polypep (2-0 ml) that contained vehicle, AVP (2 µ), AVP (14 nM) or AVP (100 µ). At the conclusion of the incubation, the media were retrieved and stored, and the cells frozen as described above.
Activation of PKC Cells representing the vehicle-and Cx-pretreatment groups were incubated for 5 h in DMEM:F12:polypep (2-0 ml) that contained either vehicle or phorbol myristate acetate (PMA; 1 µ ). At the conclusion of the incubation, the media were retrieved and stored, and the cells frozen as described above.
Inhibition of protein synthesis Cells representing the vehicle-and Cx-pretreatment groups were designated to be either cycloheximide (CHX)-present or -absent. CHX-present cells began being treated with CHX ( µ ) during the 1-h equilibration with serum-free medium and this was continued through the acute treatment. Cells were incubated for 5 h in DMEM:
F12:polypep (2-0 ml) that contained either vehicle or AVP (100 µ). At the conclusion of the incubation, the media the intact vehicle-pretreated (6-5 ±1-2) and CRHpretreated (6-9 ± 0-7) groups.
In CRH-target-depleted populations, the effect of CRH on ACTH secretion was indistinguishable from basal secretion, whereas in vehicle-pretreated (81 ± 14 ng/well) and CRH-pretreated (60 ± 17) cells CRH significantly stimulated ACTH secretion, and the re¬ sponses to the CRH challenge were similar in the two groups.
As in earlier studies on ovine cells in this (Schwartz et al. 1991 ) and other laboratories (Familari et Activation of PKC Exposure of vehicle-pretreated cells to PMA ( µ ) produced effects identical to those already reported (Liu et al. 1990 ). ACTH secretion (318 ± 16 ng/well) and total ACTH (331 ± 26 ng/well) were elevated compared with intact, vehicle-treated populations (6-5±l-2ng/ well ACTH secretion; 116 ± 15 ng/well total ACTH).
In contrast, there was no effect on POMC mRNA (90 ±10% of control). In CRH-target-depleted popu¬ lations as well, PMA increased ACTH secretion (120 ± 17 ng/well) without effect on POMC mRNA levels (185 ±35% compared with the control in this group, 168 ±9%).
Inhibition ofprotein synthesis
Given that certain secretory responses appeared to be associated with increased levels of POMC mRNA, while others were not, we extended the studies to determine the contribution of newly synthesized ACTH to the secretion after pretreatment with vehicle or Cx, in the presence or absence of AVP. This was accomplished by measuring the effects of protein synthesis inhibition by CHX on ACTH secretion and on cellular POMC mRNA. These data are summarized in Fig. 5 . CHX (10 µ ) had no significant effect on POMC mRNA levels in any of the groups. Basal ACTH secretion in intact populations and the secretory responses to AVP in both vehicle-and Cx-pretreated populations were decreased by approximately 35%. In contrast, basal ACTH secretion in Cx-pretreated popu¬ lations (which was elevated compared with vehicle pre¬ treatment) was decreased by 65 ± 13%, and this was the only group in which the effect of CHX was found to be statistically different from any of the others ( <0 5).
Comparison of effects of Cx immediately after treatment and following 3 days of recovery Two experiments were dedicated to examining the effects on POMC mRNA levels of elimination of CRH-target cells only (i.e. without any subsequent, acute incubation). We compared the immediate effects of Cx with those after the 3-day recovery period, because the initial results (Fig. 3) (Mercer et al. 1989) and inhibited inositol phosphate generation in response to AVP (Bilezikjian et al. 1987) . In contrast, disconnection of the pituitary from the hypothalamus (thus removing the CRH influence) is associated with elevated POMC mRNA levels and ACTH secretion (Clarke et al. 1986 ). (Autelitano & Sheppard 1993) . In rat and human cortico¬ trophs, cyclic AMP (cAMP) also increases POMC and the POMC gene has been mapped to include a CRHresponsive element (Gagner & 
